BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tandon P, Montano-Loza AJ, Lai JC, Dasarathy S, Merli M. Sarcopenia and frailty in decompensated cirrhosis. J Hepatol 2021;75 Suppl 1:S147-62. [PMID: 34039486 DOI: 10.1016/j.jhep.2021.01.025] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Sideris GA, Tsaramanidis S, Vyllioti AT, Njuguna N. The Role of Branched-Chain Amino Acid Supplementation in Combination with Locoregional Treatments for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis. Cancers 2023;15:926. [DOI: 10.3390/cancers15030926] [Reference Citation Analysis]
2 Meena BL, Taneja S, Tandon P, Sahni N, Soundararajan R, Gorsi U, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. Home-based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: A randomized clinical trial. J Gastroenterol Hepatol 2023;38:210-8. [PMID: 36268614 DOI: 10.1111/jgh.16035] [Reference Citation Analysis]
3 Hazra D, Mohamed M, Hyde AM, Rempel H, Oleschuk A, Miller A, Raman M, Taylor L, Gramlich L, Watt M, Tandon P. Nutrition and physical activity knowledge, attitudes, and practices of inpatient cirrhosis care providers. Eur J Gastroenterol Hepatol 2023. [PMID: 36719821 DOI: 10.1097/MEG.0000000000002512] [Reference Citation Analysis]
4 Endo K, Kakisaka K, Kuroda H, Miyasaka A, Takikawa Y, Matsumoto T. Annual changes in grip strength and skeletal muscle mass in chronic liver disease: observational study. Sci Rep 2023;13:1648. [PMID: 36717617 DOI: 10.1038/s41598-023-28528-w] [Reference Citation Analysis]
5 Praharaj DL, Anand AC. Nutrition in Viral Hepatitis. Curr Hepatology Rep 2023. [DOI: 10.1007/s11901-023-00596-6] [Reference Citation Analysis]
6 Canillas L, Pelegrina A, Álvarez J, Colominas-González E, Salar A, Aguilera L, Burdio F, Montes A, Grau S, Grande L, Carrión JA. Clinical Guideline on Perioperative Management of Patients with Advanced Chronic Liver Disease. Life (Basel) 2023;13. [PMID: 36676081 DOI: 10.3390/life13010132] [Reference Citation Analysis]
7 Xiong B, Yang C, Zhou C, Wu X, Huang S. TIPS placement as the first-line therapy to prevent variceal rebleeding in patients with cirrhosis and sarcopenia. Eur J Radiol 2023;158:110630. [PMID: 36455336 DOI: 10.1016/j.ejrad.2022.110630] [Reference Citation Analysis]
8 Li X, Kong X, Li R. Correlation between lipoprotein(a), albuminuria, myostatin and sarcopenia in elderly patients with type 2 diabetes. J Diabetes Complications 2023;37:108382. [PMID: 36535110 DOI: 10.1016/j.jdiacomp.2022.108382] [Reference Citation Analysis]
9 Bai J, Xu M, Peng F, Gong J, Zhao J, Song X, Li Y. Skeletal muscle mass index as a predictor of long-term cirrhosis onset in young non-cirrhotic males with acute-on-chronic liver failure. Front Nutr 2022;9:1071373. [PMID: 36618679 DOI: 10.3389/fnut.2022.1071373] [Reference Citation Analysis]
10 Sano A, Inoue J, Kakazu E, Ninomiya M, Iwata T, Tsuruoka M, Sato K, Onuki M, Sawahashi S, Masamune A. Omega-3 polyunsaturated fatty acids are associated with sarcopenia in patients with liver cirrhosis and hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-2344312/v1] [Reference Citation Analysis]
11 Zeng X, Shi Z, Yu J, Wang L, Sun C, Luo Y, Shi P, Lin Y, Chen Y, Guo J, Zhang C, Xie W. Skeletal Muscle Alterations Indicate Poor Prognosis in Cirrhotic Patients: A Multicentre Cohort Study in China.. [DOI: 10.21203/rs.3.rs-2289988/v1] [Reference Citation Analysis]
12 Zhang M, Zhang L, Hu Y, Wang Y, Xu S, Xie X, Xu T, Li Z, Jin H, Liu H. Sarcopenia and echocardiographic parameters for prediction of cardiovascular events and mortality in patients undergoing maintenance hemodialysis. PeerJ 2022;10:e14429. [PMID: 36444383 DOI: 10.7717/peerj.14429] [Reference Citation Analysis]
13 Ismond KP, Spiers JA, Tandon P. Identifying opportunities for hepatic encephalopathy self-management: A mixed methods systematic review and synthesis. Canadian Liver Journal 2022. [DOI: 10.3138/canlivj-2022-0025] [Reference Citation Analysis]
14 Zhang L, Fang X, Wang S, Ma S, Zhang J, Dong X, Dai J, Liu C, Gao Y. Integrated Analysis of mRNA and lncRNA Expression Profiles Reveals Regulatory Networks Associated with Decompensated Cirrhosis. Journal of Immunology Research 2022;2022:1-13. [DOI: 10.1155/2022/1805216] [Reference Citation Analysis]
15 Ayala-valverde M, Arnold J, Díaz LA, Idalsoaga F, Arrese M, Arab JP. Nutrition in Alcohol-Related Liver Disease. Curr Hepatology Rep 2022. [DOI: 10.1007/s11901-022-00591-3] [Reference Citation Analysis]
16 Miwa T, Hanai T, Nishimura K, Unome S, Maeda T, Ogiso Y, Imai K, Suetsugu A, Takai K, Shimizu M. Usefulness of the Global Leadership Initiative on Malnutrition criteria to predict sarcopenia and mortality in patients with chronic liver disease. Hepatol Res 2022;52:928-36. [PMID: 35861232 DOI: 10.1111/hepr.13816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Goffaux A, Delorme A, Dahlqvist G, Lanthier N. Improving the prognosis before and after liver transplantation: Is muscle a game changer? World J Gastroenterol 2022; 28(40): 5807-5817 [DOI: 10.3748/wjg.v28.i40.5807] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Matthias Buechter, Guido Gerken. Liver Function—How to Screen and to Diagnose: Insights from Personal Experiences, Controlled Clinical Studies and Future Perspectives. J Pers Med 2022;12:1657. [PMID: 36294796 DOI: 10.3390/jpm12101657] [Reference Citation Analysis]
19 Haj Ali S, Abu Sneineh A, Hasweh R. Nutritional assessment in patients with liver cirrhosis. World J Hepatol 2022; 14(9): 1694-1703 [DOI: 10.4254/wjh.v14.i9.1694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Motsiuk VM, Pentiuk NO. Radiological psoas muscle parameters as a reliable tool for detection of sarcopenia and prediction of short-term survival in liver cirrhosis. Rep of Morph 2022;28:5-13. [DOI: 10.31393/morphology-journal-2022-28(3)-01] [Reference Citation Analysis]
21 Yang C, Xiong B. A comprehensive review of prognostic scoring systems to predict survival after transjugular intrahepatic portosystemic shunt placement. Portal Hypertension & Cirrhosis 2022;1:133-144. [DOI: 10.1002/poh2.28] [Reference Citation Analysis]
22 Kasper P, Tacke F, Heppner HJ, Michels G. [Liver dysfunction in geriatric patients]. Z Gerontol Geriatr 2022. [PMID: 36045275 DOI: 10.1007/s00391-022-02037-3] [Reference Citation Analysis]
23 Santos CML, Brito MD, Castro PASV, Vries TP, Viana NL, Coelho MPP, Malheiro OB, Bering T, Gonzalez MC, Teixeira R, Cambraia RD, Rocha GA, Silva LD. Metabolic-associated fatty liver disease is associated with low muscle mass and strength in patients with chronic hepatitis B. World J Hepatol 2022; 14(8): 1652-1666 [DOI: 10.4254/wjh.v14.i8.1652] [Reference Citation Analysis]
24 Johnston HE, Takefala TG, Kelly JT, Keating SE, Coombes JS, Macdonald GA, Hickman IJ, Mayr HL. The Effect of Diet and Exercise Interventions on Body Composition in Liver Cirrhosis: A Systematic Review. Nutrients 2022;14:3365. [DOI: 10.3390/nu14163365] [Reference Citation Analysis]
25 Guo G, Li C, Hui Y, Mao L, Sun M, Li Y, Yang W, Wang X, Yu Z, Fan X, Jiang K, Sun C. Sarcopenia and frailty combined increases the risk of mortality in patients with decompensated cirrhosis. Ther Adv Chronic Dis 2022;13:20406223221109651. [PMID: 35875834 DOI: 10.1177/20406223221109651] [Reference Citation Analysis]
26 Ekramzadeh M, Santoro D, Kopple JD. The Effect of Nutrition and Exercise on Body Composition, Exercise Capacity, and Physical Functioning in Advanced CKD Patients. Nutrients 2022;14:2129. [DOI: 10.3390/nu14102129] [Reference Citation Analysis]
27 Tejedor M, Selzner N, Berenguer M. Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List? Transplantation 2022. [PMID: 35594480 DOI: 10.1097/TP.0000000000004163] [Reference Citation Analysis]
28 Nguyen M, Mukaneza Y, Tremblay M, Huard G, Tang A, Rose CF, Bémeur C. Renal dysfunction independently predicts muscle mass loss in patients following liver transplantation. CanLivJ. [DOI: 10.3138/canlivj-2021-0042] [Reference Citation Analysis]
29 Rich NE, Phen S, Desai N, Mittal S, Yopp AC, Yang JD, Marrero JA, Iyengar P, Infante RE, Singal AG. Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis. Clin Gastroenterol Hepatol 2022;20:e1157-69. [PMID: 34555519 DOI: 10.1016/j.cgh.2021.09.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
30 O'leary JG, Bajaj JS. MELD 3.0: One Small Step for Womankind or One Big Step for Everyone? Gastroenterology 2022;162:1780-1. [PMID: 34529990 DOI: 10.1053/j.gastro.2021.09.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Liu H, Nguyen HH, Yoon KT, Lee SS. Pathogenic Mechanisms Underlying Cirrhotic Cardiomyopathy. Front Netw Physiol 2022;2:849253. [DOI: 10.3389/fnetp.2022.849253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Li C, Zhao C, Yu Z, Yang W, Sun M, Li Y, Guo G, Hui Y, Wang X, Fan X, Wang B, Zhang J, Sun C. Low free triiodothyronine levels are associated with frail phenotype in hospitalized inpatients with cirrhosis. Postgrad Med 2022. [PMID: 35382681 DOI: 10.1080/00325481.2022.2063487] [Reference Citation Analysis]
33 Mauro E, Diaz JM, Garcia-Olveira L, Spina JC, Savluk L, Zalazar F, Saidman J, De Santibañes M, Pekolj J, De Santibañes E, Crespo G, Abraldes JG, Gadano A. Sarcopenia HIBA score predicts sarcopenia and mortality in patients on the liver transplant waiting list. Hepatol Commun 2022;6:1699-710. [PMID: 35238487 DOI: 10.1002/hep4.1919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, Engelmann C, Zhang P, Jeong JY, van Vugt JLA, Xiao H, Deng H, Gao X, Ye Q, Zhang J, Yang L, Cai Y, Liu Y, Liu N, Li Z, Han T, Kaido T, Sohn JH, Strassburg C, Berg T, Trebicka J, Hsu YC, IJzermans JNM, Wang J, Su GL, Ji F, Nguyen MH. Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis. J Hepatol 2022;76:588-99. [PMID: 34785325 DOI: 10.1016/j.jhep.2021.11.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 27.0] [Reference Citation Analysis]
35 Ayares G, Idalsoaga F, Díaz LA, Arnold J, Arab JP. Current Medical Treatment for Alcohol-Associated Liver Disease. J Clin Exp Hepatol 2022;12:1333-48. [PMID: 36157148 DOI: 10.1016/j.jceh.2022.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Wang S, Tandon P. The Impact of Sarcopenia, Frailty, and Malnutrition on Further Decompensation. Portal Hypertension VII 2022. [DOI: 10.1007/978-3-031-08552-9_50] [Reference Citation Analysis]
37 Kim SE, Kim DJ. Sarcopenia as a prognostic indicator of liver cirrhosis. J Cachexia Sarcopenia Muscle 2021. [PMID: 34812591 DOI: 10.1002/jcsm.12869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
38 Ramai D, Dang-Ho KP, Kewalramani A, Bandaru P, Sacco R, Giacomelli L, Shah A, Papa S, Cappellini F, Perversi F, di Nunzio S, Facciorusso A. Hospital Frailty Risk Score Is Independently Associated with Mortality and Encephalopathy in Hospitalized Patients with Hepatocellular Carcinoma. Biomedicines 2021;9:1693. [PMID: 34829921 DOI: 10.3390/biomedicines9111693] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Grüngreiff K, Gottstein T, Reinhold D, Blindauer CA. Albumin Substitution in Decompensated Liver Cirrhosis: Don't Forget Zinc. Nutrients 2021;13:4011. [PMID: 34836265 DOI: 10.3390/nu13114011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Siramolpiwat S, Kiattikunrat K, Soontararatpong R, Pornthisarn B, Vilaichone RK, Chonprasertsuk S, Bhanthumkomol P, Nunanun P, Issariyakulkarn N. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis. Scand J Gastroenterol 2021;56:1210-9. [PMID: 34338110 DOI: 10.1080/00365521.2021.1957497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
41 Saeki C, Tsubota A. Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:899. [PMID: 34575048 DOI: 10.3390/life11090899] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
42 Jalan R, Szabo G. New concepts and perspectives in decompensated cirrhosis. J Hepatol 2021;75 Suppl 1:S1-2. [PMID: 34039481 DOI: 10.1016/j.jhep.2020.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]